The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 31, 2020

Filed:

Mar. 21, 2017
Applicant:

Novo Nordisk A/s, Bagsvaerd, DK;

Inventors:

Henrik Bengtsson, Taastrup, DK;

Toke Folke Christensen, Soeborg, DK;

Louise Wagner Noergaard, Valby, DK;

Mads Schenstroem Stefansen, Copenhagen OE, DK;

Assignee:

Novo Nordisk A/S, Bagsvaerd, DK;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61M 5/24 (2006.01); G16H 40/63 (2018.01); G06F 19/00 (2018.01); A61B 5/145 (2006.01); A61M 5/315 (2006.01); A61M 5/32 (2006.01); G06Q 50/22 (2018.01); G16H 10/65 (2018.01); A61M 5/172 (2006.01); A61M 5/31 (2006.01);
U.S. Cl.
CPC ...
A61M 5/24 (2013.01); A61B 5/14532 (2013.01); A61M 5/1723 (2013.01); A61M 5/3157 (2013.01); A61M 5/31568 (2013.01); A61M 5/3202 (2013.01); G06F 19/3456 (2013.01); G06F 19/3468 (2013.01); G06Q 50/22 (2013.01); G16H 10/65 (2018.01); G16H 40/63 (2018.01); A61M 2005/3125 (2013.01); A61M 2005/3126 (2013.01); A61M 2205/50 (2013.01); A61M 2205/52 (2013.01); A61M 2205/8206 (2013.01); A61M 2230/201 (2013.01);
Abstract

A system for optimizing a patient's basal insulin dosage regimen over time, adapted to determine from blood glucose values whether and by how much to vary a patient's present recommended amount of the insulin-containing drug in order to maintain the patient's future blood glucose level measurements within a predefined range, and wherein a given blood glucose value is disregarded if no patient-actuated operation being indicative of the administration of a dose of an insulin containing drug has been detected in a pre-defined amount of time prior to the determination of the given blood glucose value.


Find Patent Forward Citations

Loading…